746837
Last Update Posted: 2010-12-02
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
26 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
AZD5672 Absolute Bioavailability Study
The purpose of the study is to estimate the absolute bioavailability at steady state of 2 doses of AZD5672 (50 mg and 150 mg administered orally once daily)
Eligibility
Relevant conditions:
Healthy Volunteers
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov